2025/07/24 09:44:02
Economic Daily Liu Meien
Abstract
Since its founding in 2017, the Chinese Charity Festival is dedicated to recognizing companies and individuals who actively practice Corporate Social Responsibility (CSR) and ESG sustainable development.
Translab International Ltd. was named the 2025 "Chinese Charity Ambassador
Recognized by the Chinese Charity Festival, Taiwanese biotech brand “Translab International Ltd.”, for its long-term commitment to health supplement promotion and social welfare, has earned General Manager Johnson Huang Mingxin the 2025 “Chinese Charity Ambassador” award. Established in 2017, the Chinese Charity Festival is dedicated to recognizing companies and individuals who actively practice Corporate Social Responsibility (CSR) and ESG sustainable development, bringing the power of philanthropy to every corner of society.
Johnson Huang Mingxin, General Manager of Translab International Ltd., led the team to promote health supplements and public welfare, and was awarded the 2025 Chinese Public Welfare Ambassador, igniting new hope in life. Translab International / Provided
Translab International Ltd. combines scientific research with public welfare to ignite new hope for life
Translab International Ltd. has always upheld the core philosophy of “rooted in scientific research and prioritizing the well-being of people,” adhering to rigorous scientific validation in the creation of each product. We actively practice corporate social responsibility, deeply cultivating medical institutions and communities, and collaborating with professional channels to continuously bridge the gap between research and care.
This recognition not only highlights the company’s long-term investment, but also allows “Translab (FOII) Second Generation Small Molecule Fucoidan” to be more widely recognized for its unwavering commitment to scientifically addressing health needs and protecting countless families in Taiwan.
Recognized, Warm to Society – Applications Open for Limited-edition "Translab’s Warm Care Packages
To express gratitude for the recognition as a “Chinese Public Welfare Ambassador,” Translab (FOII) Second Generation Small Molecule Fucoidan is releasing a limited edition of 1,000 “Translab’s Warm Care Packages,” a tangible gesture of giving back to society and spreading hope. Each package includes Transalb’s (FOII) Second Generation Small Molecule Fucoidan Energy Drink (FREE Package), a free consultation card with a nutritionist, and many other gifts. We hope to accompany those experiencing critical periods and ignite new hope together. Applications are open now until supplies are filled.
To give back to society, Translab (FOII) Second Generation Small Molecule Fucoidan has launched the “Translab’s Warm Care Package,” limited to 1,000 free applications, to help people obtain nutritional support during their critical health period and ignite new hope for life.
How to receive the “Translab’s Warm Care Package”:
Please click on the event website and link your APP “LINE account” to become a “Translab” official website member to add the free warm care package to your shopping cart. The “Translab Warm Care Package” will be shipped (Shipping Area Within Taiwan Only) starting August 1, 2025. Each member is limited to one, and there are only 1,000 packages available, while supplies last.
Event website:
From product strength to care power, implementing the transmission of love
Based on scientific research and human clinical validation, “Translab (FOII) Second Generation Small Molecule Fucoidan” has not only garnered recognition from medical professionals, but also further transformed “product power” into “care power.” Over the past three years, Translab International Ltd. has actively promoted the “Critical Period Nutrition Support Program,” collaborating with over 100 medical institutions and over 150 departments across Taiwan. Leveraging physicians and medical professionals’ recognition of the clinical applications of Translab (FOII) second-generation small molecule fucoidan for nutritional supplementation, conditioning, and post-illness nourishment, this program, combined with frontline medical staff, has identified vulnerable individuals facing nutritional bottlenecks during this critical period. Free “Translab (FOII) Second Generation Small Molecule Fucoidan” products are provided to these vulnerable individuals, helping them ignite new hope in life.
Through this model, Translab International Ltd. practices the health foundation of translational medicine and preventive medicine, and combines with medical institutions to implement the “Critical Period Nourishing Support Program.” As of this year, it has donated products worth more than NT$15 million, helping more than 300 families obtain more resources to maintain their health when facing critical periods.
General Manager Johnson Huang Mingxin said emotionally, “We’ve received so much gratitude from families, sharing how their loved ones have navigated various critical stages of their lives, from initially being unable to eat to regaining their appetite and, as a result, finding more smiles in their lives. Seeing so many cases of people successfully overcoming these sudden life-threatening challenges brings me great joy. I must also express my gratitude to our shareholders for their full support in fulfilling our social responsibility of igniting new hope in life.”
Starting from human needs, protecting health with science
Translab International has observed that most people have a high demand for fucoidan health food supplements, but are often deterred by the product’s form, taste, and ease of absorption. Therefore, through a technology licensing partnership with the National Taiwan Ocean University, the company introduced the (FOII) second-generation small molecule fucoidan patented extraction technology. After removing useless precipitated impurities from the early generation process, it utilized its high water-soluble purity and activity to develop the world’s first “liquid form small molecule fucoidan” product, ‘Translab (FOII) Second Generation Small Molecule Fucoidan Functional Drink’, which provides support to the body during critical periods, helping to promote appetite and regulate physical fitness. As Taiwan’s leading brand of liquid form small molecule fucoidan, Translab International Ltd. is committed to developing high-quality, health professionally recommended fucoidan functional drinks.
Before the product was launched, it invited many people who were facing critical periods and needed to adjust their physical fitness or strengthen nutritional supplements and had a demand for taste to try it, so as to optimize the product’s palatability through real feedback. General Manager Johnson Huang Mingxin said, “We hope to lower the barrier to entry for consumption, making it easier for seniors, those with swallowing difficulties, or those seeking nutritional support during critical periods to consume and feel safe about their nutrition.”
Translab (FOII) 2nd generation small molecule fucoidan functional Drink utilizes enzyme hydrolysis, ultra-pressure filtration, and patented instant dissolution technology to rigorously control the molecular size of its small-molecule fucoidan, while removing excess substances to retain only the key active ingredients. Produced entirely in a PIC/S GMP pharmaceutical facility, it complies with ISO 22000 and HACCP international food safety standards. Its products have been recognized with the SNQ National Safety & Quality Symbol, the National Taiwan Brand Yushan Award, and the Taiwan Innovation Technology Expo Invention Award, demonstrating its rigorous commitment to quality.
Partnering with pharmacies and communities to bring health into everyday life
Currently, Translab (FOII) second-generation small molecule fucoidan functional drink is available in over 1,200 pharmacies across Taiwan, including well-known chain stores such as BigTree Pharmacy, YourChance, Medfirst, and WellCare. They are collaborating with pharmacists to provide professional advice and supplement services. Whether you’re looking for information on where to buy fucoidan, product recommendations, or nutritional supplements, you can get immediate assistance at major pharmacies across Taiwan. Going forward, Translab International Ltd. will continue to collaborate with community pharmacies and primary care clinics to promote public welfare initiatives, bringing health knowledge and resources to every household and narrowing the care gap.
Translab’s (FOII) second-generation small molecule fucoidan is committed to public welfare, providing free professional health advice and nutritional consultation, and connecting with the “Translab Warm Care Package” campaign to bring health supplements and care to every family.
Sustainable commitment, lighting up more hope
Facing with the challenges of an aging population and health, Translab International firmly believes that the biotech industry must not only pursue market share but also shoulder a social mission. General Manager Johnson Huang Mingxin emphasized, “Public welfare isn’t just a slogan in a report; it’s implemented in every service, every product, and every community activity.” Going forward, the company will continue to develop more nutritional products that are relevant to people’s lives, grounded in science and expertise, and become a model for CSR and ESG practices.
“Translab (FOII) 2nd generation small molecule fucoidan Functional Drink” may seem simple, but it inspires courage to face life’s challenges, found on countless family dinner tables and during post-illness recuperation. Translab International hopes to ignite new hope for more lives in Taiwanese society through continuous research and development and social welfare initiatives.
